Page last updated: 2024-09-04

methyl 5-aminolevulinate and Cancer of Skin

methyl 5-aminolevulinate has been researched along with Cancer of Skin in 169 studies

Research

Studies (169)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	51 (30.18)	29.6817
2010's	106 (62.72)	24.3611
2020's	12 (7.10)	2.80

Authors

Authors	Studies
Callan, JF; Jack, IG; Kavanagh, ON; Loan, P; McEwan, C; McHale, AP; McKenna, K; Nesbitt, H; Nicholas, D	1
de Haas, ERM; de Rooij, MJM; Kelleners-Smeets, NWJ; Kessels, JPHM; Kreukels, H; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ	1
Dong, K; Lultschik, S; Sapra, S; Sharma, K; Tran, J	1
Durães, SMB; Issa, MCA; Pereira, AD; Pires, M; Pires, MTF	1
García-Malinis, AJ; Gilaberte, Y; Gracia-Cazaña, T	1
Fu, C; Liu, Q; Qin, L; Wang, BC; Zeng, XY	1
Kulakov, EL; Logan, IT; Perrett, CM	1
Ben Brahim, E; Ben Lagha, I; Ben Tanfous, A; Chaabani, M; Fenniche, S; Hammami-Ghorbel, H; Koubaa, W; Zaouak, A	1
Alcantara-Nicolas, F; Canseco-Martin, M; Fernandez-Gonzalez, P; Fonda-Pascual, P; Lopez-Galan, C; Sanchez-Los Arcos, L; Vidal-Asensi, S	1
Brebi, P; Buchegger, K; Ili, C; Kurachi, C; León, D; Mora-Lagos, B; Riquelme, I; Roa, JC; Schafer, F; Silva, R; Viscarra, T; Zanella, L	1
Cerpes, U; Legat, FJ; Repelnig, ML; Weger, W; Wolf, P	1
Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC	1
Feldman, SR; Heron, CE	1
Abdelrahman, W; Azzopardi, E; Azzopardi, EA; Barbara, C; Camilleri, L; Clementoni, MT; Miles, N; Murison, M; O'Leary, B; Yarrow, J	1
Gilaberte, Y; González, S; Gracia-Cazaña, T; Juarranz, A	1
de Haas, ERM; Kelleners-Smeets, NWJ; Kessels, JPHM; Kreukels, H; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Pelt, H	1
Aguilera, J; Gilaberte, Y; González, S; Gracia-Cazaña, T; Herrera-Ceballos, E; Juarranz, Á; López-Navarro, N; Salazar, N; Vera-Álvarez, J	1
Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA	1
Aschoff, R; Berking, C; Dirschka, T; Dominicus, R; Ekanayake-Bohlig, S; Gertzmann, A; Gröne, D; Gupta, G; Hauschild, A; Hübinger, F; Ibbotson, S; Jasnoch, V; Keohane, S; Kurzen, H; Lübbert, H; Morton, CA; Ockenfels, HM; Ostendorf, R; Radny, P; Reinhold, U; Schmitz, B; Schulze, HJ; Sebastian, M; Staubach, P; Stege, H; Szeimies, RM; Ulrich, M; Ziabreva, I	1
Buendía-Castaño, D; Carrillo-Gijón, R; Fernández-González, P; Harto-Castaño, A; Pérez-García, B; Pindado-Ortega, C	1
Cazzaniga, S; Hunger, RE; Seyed Jafari, SM	1
Szeimïes, RM	2
Dirschka, T; Novak, B; Rybarski, M; Schmitz, L	1
Ibbotson, S	1
Kim, HJ; Song, KH	1
Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV	1
Apalla, Z; Ioannides, D; Kirmanidou, E; Lallas, A; Lazaridou, E; Sideris, N; Sotiriou, E; Vakirlis, E; Vrani, F	1
Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ	1
Dawe, RS; Ibbotson, SH; Lydon, E	1
Ianhez, M	1
Braun, R; Christensen, E; Dotterud, LK; Foss, OA; Olasz, A	1
Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ	1
Aguilar-Bernier, M; de Troya Martín, M; Rivas-Ruiz, F; Rodríguez-Barón, D; Segura-Palacios, JM	1
Alique-García, S; Borbujo, J; Company-Quiroga, J; Hernández Núñez, A; Sánchez Campos, A	1
Alberdi, E; Cobos, M; Gómez, C	1
Gilaberte, Y; González, S; Gracia-Cazaña, T; Juarranz, Á; Lucena, SR; Mascaraque, M; Vera-Álvarez, J	1
Chia, HY; Chong, WS; Chuah, SY; Kuan, LY; Teoh, YL; Thng, TGS	1
Aeuyung, K; Ghattaura, A; James, W; Javed, M; Murison, M; O'Leary, B; Shokrollahi, K; Whitaker, IS	1
Arbustini, E; Borroni, RG; Brazzelli, V; Carugno, A; Rivetti, N	1
Chaves, Y; Festa-Neto, C; Niwa, A; Sanches, JA; Szeimies, RM; Torezan, L	1
Lippert, J; Smucler, R; Vlk, M	1
Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D	1
Bauzá, A; Gilaberte, Y; Martín-Santiago, A; Miguélez, A	1
Kloser, A; Lee, PK	1
Kim, KH; Ko, DY; Song, KH	1
Ali, FR; Collier, NJ; Lear, JT	1
Basset-Seguin, N	1
Casie Chetty, N; Hemmant, B; Skellett, AM	1
Banzhaf, CA; Jemec, GB; Mogensen, M; Themstrup, L	1
Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I	1
Caldas, A; Jeunon, T; Marques-da-Costa, J; Ortiz, B; Valente, L; Zink, BS	1
Bagnato, VS; Buzzá, HH; de Andrade, CT; Greco, C; Inada, NM; Kurachi, C; Moriyama, LT; Pires, L; Ramirez, DP; Salvio, AG; Vollet Filho, JD	1
Bardazzi, F; Burtica, EC; Giordano, F; Loi, C; Magnano, M; Patrizi, A	1
Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E	1
Liang, WM; Lim, KS; Tan, WP; Theng, TS	1
Anderson, RR; Haak, CS; Haedersdal, M; Paasch, U; Thaysen-Petersen, D; Togsverd-Bo, K; Wulf, HC	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; Steijlen, PM	1
Bellnier, DA; Foster, TH; Henderson, BW; Paquette, AD; Rohrbach, DJ; Shi, Y; Sunar, U; Wilding, G; Zeitouni, NC	1
Colli, C; Fluehler, C; Gatti, A; Trevisan, G	1
Reygagne, P; Youssef, AA	1
Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM	1
Ibbotson, SH; Kulyk, O; Moseley, H; Samuel, ID; Valentine, RM	1
Choi, SH; Kim, KH; Song, KH	2
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K	1
Gillstedt, M; Paoli, J; Tarstedt, M; Wennberg Larkö, AM	1
Blokx, WA; Gerritsen, MJ; Hendriks, JC; Hoogedoorn, L; Knuiman, GJ; van de Kerkhof, PC; van Erp, PE	1
Anzalone, A; Cardone, M; Carlesimo, M; De Vita, G; Di Nunno, D; Fortuna, MC; Garelli, V; Mari, E; Pranteda, G; Rossi, A	1
Han, J; Li, J; Lin, H; Luo, X; Ye, Z; Yu, J; Zhao, Y; Zou, Y	1
Höök-Nikanne, J; Jeskanen, L; Kluger, N	1
Mühlstädt, M	1
Hambly, R; Lenane, P; Mansoor, N; Moloney, FJ; Quinlan, C; Ralph, N; Shah, Z	1
Berking, C; Bierhoff, E; Braunmühl, TV; Hartmann, D; Niculescu, L; Ruzicka, T	1
Hambly, RA; Lenane, P; Mansoor, N; Moloney, FJ; Quinlan, C; Ralph, N; Shah, Z	1
Lear, JT; Madan, V; Murphy, JV; West, CA	1
de Berker, D; Dummer, R; Frambach, Y; Ibbotson, S; Kerrouche, N; Murrell, DF; Rubel, D; Szeimies, RM; Villemagne, H	1
Calvieri, S; Curzio, M; Devirgiliis, V; Gobbi, S; Panasiti, V; Roberti, V; Rossi, M	1
Arenberger, P; Frey, T; Hegyi, J	1
Coscojuela, C; Ferrer, C; Frias, MP; Gilaberte, Y; González, S	1
Bédane, C; Bonnetblanc, JM; Doffoel-Hantz, V; Durox, H; Marin, B; Sparsa, A	1
Attili, SK; Ibbotson, SH	1
Kotimäki, J	1
Arpaia, N; Cassano, N; Fai, D; Romano, I; Vena, GA; Vestita, M	1
Ferguson, J; Lesar, A; Moseley, H	1
Christensen, E; Funk, J; Helsing, P; Kroon, S; Mørk, C; Soler, AM; Stang, HJ; Vatne, O; Warloe, T	1
Gerritsen, RM; Kleinpenning, MM; van de Kerkhof, PC	1
Caekelbergh, K; Lamotte, M; Leroy, B; Nikkels, AF; Verhaeghe, E; Vincent, R	1
Anderson, C; Barnetson, R; El-Azhary, RA; Foley, P; Freeman, M; Gebauer, K; Gibson, LE; Jarratt, MT; Kossard, S; Lowe, NJ; Menter, A; Murrell, DF; Oseroff, AR; Pariser, DM; Rich, P; Siller, G; Tope, WD	1
Haedersdal, M; Lerche, CM; Poulsen, T; Togsverd-Bo, K; Wulf, HC	1
Bloznelyte-Plesniene, L; Liutkeviciūte-Navickiene, J; Mordas, A; Simkute, S	1
Aguilar, M; Benítez, N; de Troya, M; González, M; Martin, L	1
Murrell, DF; Sebaratnam, DF; Venugopal, SS	1
Campbell, S; Curnow, A; Tyrrell, J	1
Choi, JW; Huh, CH; Jung, JY; Kim, BJ; Lee, JH; Park, KC; Yeon, JH; Youn, SW	1
Campbell, SM; Curnow, A; Tyrrell, JS	1
Debu, A; Dereure, O; Girard, C; Guillot, B; Kluger, N	1
Fasanmade, A; Godden, D; Milne, J; Taylor, D	1
De Las Heras, E; Fernández-Guarino, M; Harto, A; Jaén, P; Montull, C; Pérez-García, B	1
Boiy, A; de Witte, PA; Roelandts, R	1
Calzavara-Pinton, PG; Cesinaro, AM; Del Giovane, C; Fantini, F; Greco, A; Peris, K; Surrenti, T; Venturini, M; Zane, C	1
Damian, DL; Frost, GA; Halliday, GM	1
Campbell, SM; Curnow, A; Tyrrell, J	1
Attili, SK; Dawe, R; Ibbotson, S	1
Hanke, CW; Petersen, J; Tierney, E	1
Carrasco, E; Cogno, IS; Gilaberte, Y; Juarranz, A; Milla, LN; Rivarola, VA; Rodríguez, ME; Sanz-Rodríguez, F; Zamarrón, A	1
Campbell, SM; Curnow, A; Morton, C; Tyrrell, JS	1
Ericson, MB; Gillstedt, M; Halldin, CB; Larkö, O; Paoli, J; Sandberg, C; Wennberg, AM	1
Bogner, P; Kitagawa, KH; Zeitouni, NC	1
Basset-Seguin, N; Livideanu, C; Mazereeuw-Hautier, J; Meyer, N; Paul, C; Pauwels, C; Viraben, R	1
Cavicchini, S; Fiorani, R; Ghislanzoni, M; Girgenti, V; Sala, F; Serini, SM	1
Bosch, R; Castillo, R; Herrera, E; Herrera-Acosta, E; López, N; Meyer-Gonzalez, T	1
Costa, V; Fernandes, I; Selores, M; Torres, T	1
Dellavalle, R; Francis, SO; Gamble, RG; Mason, MN; Prado, R; Wing, G	1
Kragballe, K; Lindberg-Larsen, R; Sølvsten, H	1
Baltás, E; Gaál, M; Gyulai, R; Kemény, L; Ocsai, H; Oláh, J; Otrosinka, S	1
Baron, ED; Lee, Y	1
Baek, JW; Jeon, YS; Kang, DY; Kang, JS; Kim, ST; Suh, KS	1
Andrew, S; Cotterell, L; Evangelou, G; Farrar, MD; Rhodes, LE; Tosca, AD; Watson, RE	1
Kriz, M; Lippert, J; Smucler, R; Vlk, M	1
Haedersdal, M; Lerche, CM; Philipsen, PA; Poulsen, T; Togsverd-Bo, K; Wulf, HC	1
Guleng, GE; Helsing, P	1
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C	1
Baldursson, BT; Bäumler, W; Enk, CD; Fabricius, S; Heydenreich, J; Rosso, S; Wiegell, SR; Wulf, HC	1
Allen, J; Blake, E; Curnow, A; Shore, A; Thorn, C	1
Hearn, R; Ibbotson, SH; Valentine, R	1
Bessis, D; Debu, A; Dereure, O; Du Thanh, A; Girard, C; Guillot, B	1
Calzavara-Pinton, PG; Gonzàlez, S; Sala, R; Venturini, M	1
Allen, J; Blake, E; Campbell, S; Curnow, A; Helliwell, P; Mathew, J	1
Cognetta, AB; Green, WH; Hatfield, HK; Wolfe, CM	1
Segura, S	1
Skødt, V; Wiegell, SR; Wulf, HC	1
Gardlo, K; Ruzicka, T	1
de Rie, M; Enström, Y; Goulden, V; Grob, JJ; Groves, R; Morken, T; Rhodes, LE; Varma, S; Wolf, P; Wong, GA	1
Stiefelhagen, P	1
Perry, CM; Scott, LJ; Siddiqui, MA	1
Foley, P; Sinclair, R; Tan, B	1
Binswanger, U; Burg, G; Dragieva, G; Dummer, R; Hafner, J; Kempf, W; Prinz, BM	1
Podda, M	1
Czarnecki, D; Elliott, T; Francis, D; Gebauer, K; Murrell, D; Nguyen, R; Reid, C; Sheridan, A; Spelman, L; Vinciullo, C; Weightman, W	1
Larkö, O	1
Foley, P	1
Bonnekoh, B; Franke, I; Gollnick, H; Kreutzer, K	1
Cerio, R; Goldsmith, PC; Harwood, CA; McGregor, JM; Perrett, CM; Proby, CM; Tan, SK	1
Breuninger, H	1
Angell-Petersen, E; Giercksky, KE; Moan, J; Peng, Q; Soler, AM; Sørensen, R; Warloe, T	1
Bissonnette, R; Caty, V; Liu, Y; Viau, G	1
Fritsch, C; Ruzicka, T	1
Bakker-Wensveen, CA; Pavel, S; Stender, I; Wulf, HC	1
Calzavara-Pinton, P; Sala, R; Venturini, M; Zane, C	1
Haedersdal, M; Philipsen, PA; Skiveren, J; Wiegell, SR; Wulf, HC	1
Annemans, L; Caekelbergh, K; Lambert, J; Roelandts, R	1
Morton, CA	1
Bissonnette, R	1
Basset-Seguin, N; Bissonnette, R; Braathen, LR; Foley, P; Morton, CA; Pariser, D; Roelandts, R; Szeimies, RM; Wennberg, AM	1
Calzavara-Pinton, PG; Sala, R; Venturini, M	1
Lehmann, P	1
Nikkels, AF; Piérard, GE; Quatresooz, P; Thirion, L	1
Alfsen, GC; Axcrona, K; Brennhovd, B; Giercksky, KE; Warloe, T	1
Anstey, A; Bachmann, I; de Rie, MA; Goulden, V; Leifsdottir, R; Rhodes, LE; Richard, MA; Wolf, P; Wong, GA; Yu, RC	1
Brownell, I	1
Campbell, SM; Curnow, A; Helliwell, P; Horton, S; Matthew, J; Pye, A	1
Iani, V; Ma, LW; Moan, J; Nielsen, KP	1
Campbell, S; Curnow, A; Pye, A	1
Agner, T; Bryld, LE; Dam, TN; Jungersted, JM	1
Cesinaro, AM; Fantini, F; Giannetti, A; Greco, A; Marconi, A; Peris, K; Pincelli, C; Surrenti, T; Vaschieri, C	1
Smucler, R; Vlk, M	1

Reviews

24 review(s) available for methyl 5-aminolevulinate and Cancer of Skin

Article	Year
Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis. Photodiagnosis and photodynamic therapy, 2020, Volume: 29 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2020
Interventions for basal cell carcinoma of the skin. The Cochrane database of systematic reviews, 2020, 11-17, Volume: 11 Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2020
Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018, Volume: 153, Issue:6 Topics: Aminolevulinic Acid; Humans; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prognosis; Skin Neoplasms; Treatment Outcome	2018
Pain perception during photodynamic therapy: why is daylight PDT with methyl aminolevulinate almost pain-free? A review on the underlying mechanisms, clinical reflections and resulting opportunities. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018, Volume: 153, Issue:6 Topics: Aminolevulinic Acid; Humans; Light; Pain; Pain Perception; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2018
Daylight photodynamic therapy for field cancerization: lessons from molecular biology. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018, Volume: 153, Issue:6 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2018
Interventions for cutaneous Bowen's disease. The Cochrane database of systematic reviews, 2013, Jun-24, Issue:6 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2013
Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT. Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:8 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Disease Progression; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; United States	2013
[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]. Annales de dermatologie et de venereologie, 2013, Volume: 140 Suppl 2 Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Precancerous Conditions; Skin Diseases; Skin Neoplasms	2013
Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis. Journal of cosmetic dermatology, 2016, Volume: 15, Issue:4 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2016
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:5 Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Skin Neoplasms	2010
A review of pain experienced during topical photodynamic therapy--our experience in Dundee. Photodiagnosis and photodynamic therapy, 2011, Volume: 8, Issue:1 Topics: Administration, Topical; Aminolevulinic Acid; Comorbidity; Female; Humans; Male; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Skin Neoplasms; United Kingdom	2011
Nonmelanoma skin cancer chemoprevention. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:11 Topics: Acitretin; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxyribonuclease (Pyrimidine Dimer); Eflornithine; Humans; Monoterpenes; Peroxisome Proliferator-Activated Receptors; Photochemotherapy; Photosensitizing Agents; Polyphenols; Retinoids; Skin Neoplasms; Viral Proteins	2011
Photodynamic therapy: current evidence and applications in dermatology. Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:4 Topics: Acne Vulgaris; Aminolevulinic Acid; Bowen's Disease; Candidiasis; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Leishmaniasis, Cutaneous; Lymphoma, T-Cell, Cutaneous; Photochemotherapy; Photosensitizing Agents; Psoriasis; Skin Neoplasms; Tinea Capitis; Warts	2011
Metvix (PhotoCure). Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:11 Topics: Administration, Topical; Aminolevulinic Acid; Animals; Clinical Trials as Topic; Humans; Ointments; Photosensitizing Agents; Skin Neoplasms; Technology, Pharmaceutical	2002
Topical methyl aminolevulinate. American journal of clinical dermatology, 2004, Volume: 5, Issue:2 Topics: Administration, Cutaneous; Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2004
Photodynamic therapy. The Australasian journal of dermatology, 2005, Volume: 46 Suppl 3 Topics: Administration, Topical; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Cryotherapy; Fluorouracil; Humans; Photochemotherapy; Photosensitizing Agents; Skin Diseases; Skin Neoplasms; Treatment Outcome	2005
Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis. The Australasian journal of dermatology, 2005, Volume: 46 Suppl 3 Topics: Adult; Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Sunlight; Treatment Outcome	2005
Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2006, Volume: 25, Issue:1-2 Topics: Aminolevulinic Acid; Fluorescence; Humans; Keratosis; Light; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2006
Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatology, photoimmunology & photomedicine, 2006, Volume: 22, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aminolevulinic Acid; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2006
Methyl aminolevulinate: actinic keratoses and Bowen's disease. Dermatologic clinics, 2007, Volume: 25, Issue:1 Topics: Aminolevulinic Acid; Bowen's Disease; Facial Dermatoses; Humans; Keratosis; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin Neoplasms; Ultraviolet Rays	2007
Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. Dermatologic clinics, 2007, Volume: 25, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2007
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Aminolevulinic Acid; Australia; Basal Cell Nevus Syndrome; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Humans; Immunocompromised Host; Incidence; Keratosis; Multicenter Studies as Topic; Patient Satisfaction; Photochemotherapy; Photosensitivity Disorders; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; United States	2007
Photodynamic therapy: update 2006. Part 2: Clinical results. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:4 Topics: Aminolevulinic Acid; Drug Approval; Humans; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Treatment Outcome	2007
Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. The British journal of dermatology, 2007, Volume: 156, Issue:5 Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2007

Trials

43 trial(s) available for methyl 5-aminolevulinate and Cancer of Skin

Article	Year
Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma. Dermatology (Basel, Switzerland), 2022, Volume: 238, Issue:6 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2022
Laser-assisted MAL-PDT associated with acoustic pressure wave ultrasound with short incubation time for field cancerization treatment: A left-right comparison. Photodiagnosis and photodynamic therapy, 2019, Volume: 28 Topics: Adult; Aged; Aminolevulinic Acid; Combined Modality Therapy; Elasticity Imaging Techniques; Female; Forearm; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Ultrasonic Waves	2019
Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial. The British journal of dermatology, 2018, Volume: 178, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. The British journal of dermatology, 2018, Volume: 179, Issue:2 Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome	2018
Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease. Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:5 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy, Needle; Bowen's Disease; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunohistochemistry; Laser Therapy; Lower Extremity; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors; Treatment Outcome	2018
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. The British journal of dermatology, 2018, Volume: 179, Issue:5 Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2018
Short incubation fractional CO Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:1 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Absorption; Skin Neoplasms; Time Factors	2019
Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017). Photodermatology, photoimmunology & photomedicine, 2019, Volume: 35, Issue:4 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Disease-Free Survival; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Survival Rate	2019
Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions. Photodiagnosis and photodynamic therapy, 2019, Volume: 26 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2019
A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:8 Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2013
A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. The British journal of dermatology, 2014, Volume: 170, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Asian People; Bowen's Disease; Female; Follow-Up Studies; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome	2014
Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions. Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Tomography, Optical Coherence	2014
Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project. Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:1 Topics: Aminolevulinic Acid; Brazil; Carcinoma, Basal Cell; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms	2014
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. The British journal of dermatology, 2014, Volume: 171, Issue:6 Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2014
Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas--a randomized clinical trial. The British journal of dermatology, 2015, Volume: 172, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Fluorescence; Humans; Laser Therapy; Lasers, Gas; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Risk Factors; Skin Neoplasms; Treatment Outcome	2015
Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. The British journal of dermatology, 2015, Volume: 172, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2015
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin. Photodiagnosis and photodynamic therapy, 2015, Volume: 12, Issue:4 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Optical Imaging; Photosensitizing Agents; Point-of-Care Systems; Protoporphyrins; Skin Neoplasms	2015
Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:5 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Lasers, Solid-State; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms	2016
Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial. JAMA dermatology, 2017, 03-01, Volume: 153, Issue:3 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Female; Humans; Lasers, Solid-State; Male; Neoplasm Invasiveness; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2017
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:11 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2008
A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin. Photodermatology, photoimmunology & photomedicine, 2009, Volume: 25, Issue:4 Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Female; Fluorescence; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Time Factors	2009
Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:11 Topics: Aged; Aminolevulinic Acid; Belgium; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome	2009
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. International journal of dermatology, 2009, Volume: 48, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome	2009
[Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients]. Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Aminolevulinic Acid; Combined Modality Therapy; Female; Fluorescence; Humans; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Occlusive Dressings; Patient Acceptance of Health Care; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Remission Induction; Skin Neoplasms; Treatment Outcome	2010
Photodynamic therapy-induced immunosuppression in humans is prevented by reducing the rate of light delivery. The Journal of investigative dermatology, 2011, Volume: 131, Issue:4 Topics: Adult; Aged; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Light; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms; Young Adult	2011
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites. The British journal of dermatology, 2011, Volume: 164, Issue:6 Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Protoporphyrins; Scalp Dermatoses; Skin Neoplasms	2011
Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease. International journal of dermatology, 2011, Volume: 50, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome	2011
Topical photodynamic therapy significantly reduces epidermal Langerhans cells during clinical treatment of basal cell carcinoma. The British journal of dermatology, 2012, Volume: 166, Issue:5 Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Langerhans Cells; Male; Middle Aged; Neutrophil Infiltration; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Lasers in medical science, 2013, Volume: 28, Issue:3 Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Oxygen; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Pressure; Protoporphyrins; Skin Neoplasms	2013
The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device. Journal of photochemistry and photobiology. B, Biology, 2012, Dec-05, Volume: 117 Topics: Aminolevulinic Acid; Biological Transport; Carcinoma, Basal Cell; Injections; Oxygen; Photosensitizing Agents; Pressure; Prodrugs; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Time Factors	2012
Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Archives of dermatology, 2004, Volume: 140, Issue:1 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms	2004
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. The British journal of dermatology, 2004, Volume: 151, Issue:1 Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Heart Transplantation; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Postoperative Period; Skin Neoplasms; Transplantation	2004
[Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (PhotoDyn 501): practical experiences in problem-patients with actinic keratoses and basal cell carcinomas]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2004, Volume: 2, Issue:12 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis; Lighting; Male; Middle Aged; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2004
Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. The Journal of investigative dermatology, 2006, Volume: 126, Issue:2 Topics: Administration, Topical; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Double-Blind Method; Female; Humans; Keratosis; Male; Microscopy, Fluorescence; Monitoring, Physiologic; Ointments; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Skin Neoplasms	2006
Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta dermato-venereologica, 2006, Volume: 86, Issue:1 Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Immunosuppression Therapy; Keratosis; Kidney Transplantation; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Skin Neoplasms; Time Factors; Treatment Outcome; Warts	2006
Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatology, photoimmunology & photomedicine, 2006, Volume: 22, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aminolevulinic Acid; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2006
Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta dermato-venereologica, 2006, Volume: 86, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Double-Blind Method; Gels; Humans; Keratosis; Middle Aged; Morphine; Pain; Photochemotherapy; Photosensitivity Disorders; Receptors, Opioid; Skin Neoplasms	2006
Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. The British journal of dermatology, 2006, Volume: 155, Issue:4 Topics: Aminolevulinic Acid; Belgium; Carcinoma, Basal Cell; Cost-Benefit Analysis; Cryosurgery; Decision Making; Drug Costs; Health Care Costs; Humans; Keratosis; Models, Econometric; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2006
Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis. Scandinavian journal of urology and nephrology, 2007, Volume: 41, Issue:6 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; Bowen's Disease; Humans; Male; Middle Aged; Penile Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2007
Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Archives of dermatology, 2007, Volume: 143, Issue:9 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Ointments; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2007
A clinical investigation to determine the effect of pressure injection on the penetration of topical methyl aminolevulinate into nodular basal cell carcinoma of the skin. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2007, Volume: 26, Issue:4 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Drug Delivery Systems; Humans; Injections, Intralesional; Microscopy, Fluorescence; Ointments; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Skin Absorption; Skin Neoplasms	2007
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:8 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Line, Tumor; Humans; In Vitro Techniques; Iron Chelating Agents; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Pyridones; Skin Neoplasms	2008
Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers in surgery and medicine, 2008, Volume: 40, Issue:2 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laser Therapy; Lasers, Solid-State; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms	2008

Other Studies

103 other study(ies) available for methyl 5-aminolevulinate and Cancer of Skin

Article	Year
Comparing the efficacy of photodynamic and sonodynamic therapy in non-melanoma and melanoma skin cancer. Bioorganic & medicinal chemistry, 2016, 07-01, Volume: 24, Issue:13 Topics: Aminolevulinic Acid; Animals; Heterografts; Humans; Melanoma; Mice, SCID; Photochemotherapy; Skin Neoplasms; Ultrasonic Therapy	2016
Non-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage. Journal of drugs in dermatology : JDD, 2023, May-01, Volume: 22, Issue:5 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Curettage; Female; Humans; Male; Middle Aged; Ontario; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2023
i-Fluorescence: Fluorescence photography with a smartphone. Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:4 Topics: Aminolevulinic Acid; Bowen's Disease; Ear Neoplasms; Ear, External; Fluorescence; Fluorescent Dyes; Humans; Lighting; Photochemotherapy; Photography; Skin Neoplasms; Smartphone; Ultraviolet Rays	2021
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome	2020
Contribution of conventional photodynamic therapy in the treatment of primary cutaneous follicle center lymphoma. International journal of dermatology, 2020, Volume: 59, Issue:6 Topics: Administration, Cutaneous; Aminolevulinic Acid; Back; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Radiotherapy; Skin; Skin Neoplasms; Treatment Outcome	2020
Treatment of cutaneous Kaposi sarcoma with methylaminolevulinate photodynamic therapy: A case series. Photodermatology, photoimmunology & photomedicine, 2020, Volume: 36, Issue:5 Topics: Adult; Aged, 80 and over; Aminolevulinic Acid; Humans; Male; Photochemotherapy; Photosensitizing Agents; Sarcoma, Kaposi; Skin Neoplasms	2020
Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells. International journal of molecular sciences, 2020, May-08, Volume: 21, Issue:9 Topics: Aminolevulinic Acid; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Ferrochelatase; Heat-Shock Proteins; Humans; Membrane Transport Proteins; Molecular Chaperones; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; Skin Neoplasms; Stress, Physiological; Superoxide Dismutase; Survivin; Symporters	2020
Methyl aminolevulinate photodynamic therapy for Bowen's disease on the fingers-Is monotherapy sufficiently effective? Photodermatology, photoimmunology & photomedicine, 2020, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Female; Fingers; Human papillomavirus 16; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2020
Ingenol Mebutate and the Treatment of Actinic Keratosis. Journal of drugs in dermatology : JDD, 2021, 01-01, Volume: 20, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome	2021
Treatment of cutaneous basal cell carcinoma with combined laser extirpation and methyl aminolevulinic acid: five-year success rates. Annals of the Royal College of Surgeons of England, 2021, Volume: 103, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Cost-Benefit Analysis; Dermatologic Surgical Procedures; Female; Follow-Up Studies; Humans; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Outcome; United Kingdom	2021
Methyl aminolevulinate photodynamic therapy combined with curettage debulking for pigmented basal cell carcinoma. Photodermatology, photoimmunology & photomedicine, 2017, Volume: 33, Issue:4 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2017
Clinical, histological and immunohistochemical markers of resistance to methyl aminolaevulinate photodynamic therapy in Bowen disease. The British journal of dermatology, 2018, Volume: 178, Issue:2 Topics: Aged; Aminolevulinic Acid; Biomarkers, Tumor; Bowen's Disease; Drug Resistance, Neoplasm; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tumor Cells, Cultured	2018
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms	2018
Two cases of large cell acanthoma successfully treated with photodynamic therapy. Dermatologic therapy, 2018, Volume: 31, Issue:4 Topics: Acanthoma; Administration, Cutaneous; Aged; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome	2018
Optimizing photodynamic therapy regimens: variables in irradiation may influence outcomes. The British journal of dermatology, 2018, Volume: 178, Issue:5 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2018
Cells to Surgery Quiz: July 2018. The Journal of investigative dermatology, 2018, Volume: 138, Issue:7 Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome	2018
Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study. The British journal of dermatology, 2019, Volume: 180, Issue:1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Female; Fluorescence; Humans; Male; Middle Aged; Pain Measurement; Pain, Procedural; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Sex Factors; Skin Neoplasms; Treatment Outcome	2019
Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment. The British journal of dermatology, 2018, Volume: 179, Issue:5 Topics: Aminolevulinic Acid; Colchicine; Forearm; Humans; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms	2018
Curettage and multiple needle puncture-assisted methyl-aminolaevulinate photodynamic therapy of basal cell carcinoma. European journal of dermatology : EJD, 2018, Dec-01, Volume: 28, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Curettage; Female; Humans; Male; Middle Aged; Needles; Photochemotherapy; Photosensitizing Agents; Punctures; Skin Neoplasms; Treatment Outcome	2018
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2019
Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate. Photodiagnosis and photodynamic therapy, 2019, Volume: 26 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2019
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy. PloS one, 2019, Volume: 14, Issue:4 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Animals; Biomarkers, Tumor; Carcinoma, Basal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Tumor Suppressor Protein p53	2019
The role of reflectance confocal microscopy in the diagnosis and management of squamous cell carcinoma in situ treated with photodynamic therapy. International journal of dermatology, 2019, Volume: 58, Issue:12 Topics: Aftercare; Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; Carcinoma, Squamous Cell; Epidermis; Female; Follow-Up Studies; Humans; Male; Microscopy, Confocal; Middle Aged; Photochemotherapy; Pilot Projects; Prospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome	2019
Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma. Annals of plastic surgery, 2014, Volume: 73, Issue:5 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lasers, Gas; Male; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2014
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer. Photodermatology, photoimmunology & photomedicine, 2013, Volume: 29, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Blood Pressure; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Hypertension; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Risk Factors; Skin Neoplasms	2013
Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:8 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Female; Humans; Lasers, Gas; Male; Microtubules; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2013
Urticaria-like reaction secondary to photodynamic therapy in 2 pediatric patients. Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8 Topics: Aminolevulinic Acid; Basal Cell Nevus Syndrome; Child; Child, Preschool; Female; Humans; Neoplasms, Multiple Primary; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Skin Neoplasms; Ultraviolet Rays; Urticaria	2013
Efficacy of photodynamic therapy for treatment of basal cell carcinoma in organ transplant recipients. Lasers in medical science, 2015, Volume: 30, Issue:4 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Drug Screening Assays, Antitumor; Female; Humans; Kidney Transplantation; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Transplant Recipients; Treatment Outcome	2015
Periocular photodynamic therapy for squamous intra-epidermal carcinoma. The Journal of dermatological treatment, 2014, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy; Bowen's Disease; Eye; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome	2014
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. The British journal of dermatology, 2014, Volume: 170, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2014
Periungual Bowen's disease successfully treated with photodynamic therapy. Photodiagnosis and photodynamic therapy, 2013, Volume: 10, Issue:4 Topics: Aminolevulinic Acid; Bowen's Disease; Hand; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2013
Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study. The Journal of dermatological treatment, 2015, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Risk Factors; Skin Neoplasms	2015
Rapid development of squamous cell carcinoma after photodynamic therapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:5 Topics: Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Squamous Cell; Disease Progression; Facial Neoplasms; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2014
A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:12 Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Pain Management; Pain Measurement; Pain Threshold; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome	2014
Photodynamic therapy for nonmelanoma skin cancer of the genital area: our experience. Acta dermatovenerologica Croatica : ADC, 2015, Volume: 23, Issue:2 Topics: Adult; Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Genitalia, Female; Genitalia, Male; Humans; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2015
Successful treatment of extramammary Paget's disease of the scalp with photodynamic therapy. International journal of dermatology, 2016, Volume: 55, Issue:5 Topics: Aged, 80 and over; Aminolevulinic Acid; Head and Neck Neoplasms; Humans; Male; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms	2016
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. International journal of dermatology, 2016, Volume: 55, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms	2016
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study. Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 154 Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays	2016
Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2016
Treatment failure in superficial basal cell carcinoma following treatment with photodynamic therapy: is this a result of underdiagnosis? Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Photochemotherapy; Retrospective Studies; Skin Neoplasms; Treatment Failure	2017
Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization. Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 162 Topics: Aged; Aminolevulinic Acid; Carcinoma, Squamous Cell; Dermoscopy; Humans; Keratosis, Actinic; Middle Aged; Photosensitizing Agents; Skin Neoplasms	2016
Photodynamic therapy-triggered bullous pemphigoid. International journal of dermatology, 2017, Volume: 56, Issue:2 Topics: Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Drug Eruptions; Facial Neoplasms; Humans; Male; Pemphigoid, Bullous; Photochemotherapy; Skin Neoplasms	2017
Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient. Dermatology (Basel, Switzerland), 2016, Volume: 232 Suppl 1 Topics: Aged; Aminolevulinic Acid; Antineoplastic Agents; Carcinogenesis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Face; Humans; Keratosis, Actinic; Kidney Transplantation; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Transplant Recipients	2016
Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection. The British journal of dermatology, 2017, Volume: 177, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Patient Selection; Photochemotherapy; Photosensitizing Agents; Recurrence; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2017
Optical coherence tomography imaging of basal cell carcinoma undergoing photodynamic therapy: A pilot study. Photodiagnosis and photodynamic therapy, 2017, Volume: 18 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Skin Neoplasms; Tomography, Optical Coherence	2017
Factors predicting pain and effect of oral analgesia in topical photodynamic therapy. Photodermatology, photoimmunology & photomedicine, 2017, Volume: 33, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analgesics; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Torso	2017
Sequential treatment of giant basal cell carcinomas. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2009, Volume: 62, Issue:10 Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2009
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatology online journal, 2008, Feb-28, Volume: 14, Issue:2 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms	2008
Unilesional mycosis fungoides treated with photodynamic therapy. A case report. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2008, Volume: 17, Issue:2 Topics: Aged; Aminolevulinic Acid; Humans; Male; Mycosis Fungoides; Photochemotherapy; Skin Neoplasms	2008
Antibacterial effect of photodynamic therapy on infected cutaneous neoplasias. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:10 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Male; Photochemotherapy; Pseudomonas aeruginosa; Serratia marcescens; Skin Diseases, Bacterial; Skin Neoplasms; Staphylococcus aureus	2008
[The value of photodynamic therapy in the treatment of Bowen's disease]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:12 Topics: Actuarial Analysis; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Female; Follow-Up Studies; Humans; Male; Photochemotherapy; Remission Induction; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Wound Healing	2008
How we treat Bowen's disease with topical photodynamic therapy in Dundee. Photodiagnosis and photodynamic therapy, 2009, Volume: 6, Issue:1 Topics: Administration, Topical; Aminolevulinic Acid; Bowen's Disease; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; United Kingdom	2009
Photodynamic therapy of eyelid basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:9 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Eyelids; Female; Follow-Up Studies; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2009
Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:3 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pain; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Salvage Therapy; Skin Neoplasms; Treatment Outcome	2009
The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp. The Journal of dermatological treatment, 2010, Volume: 21, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Facial Dermatoses; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Patient Compliance; Photochemotherapy; Precancerous Conditions; Probability; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms; Treatment Failure; Treatment Outcome	2010
Drug-induced photosensitivity. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Diuretics; Doxycycline; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Eczema; Furocoumarins; Hematoporphyrin Photoradiation; Humans; Methotrexate; Onycholysis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Porphyrins; Psychotropic Drugs; Quinolines; Skin; Skin Aging; Skin Diseases; Skin Neoplasms; Skin Pigmentation; Sulfonamides; Sunscreening Agents; Tetracycline; Ultraviolet Rays; Urticaria; Verteporfin	2009
Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice. Experimental dermatology, 2010, Volume: 19, Issue:8 Topics: Administration, Topical; Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2010
[Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester]. Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Esters; Female; Fluorescence; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Photosensitizing Agents; Precancerous Conditions; Prognosis; Protoporphyrins; Sensitivity and Specificity; Skin; Skin Neoplasms	2009
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Bowen's Disease; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2010
A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Cohort Studies; Combined Modality Therapy; Humans; Photochemotherapy; Photosensitizing Agents; Recurrence; Skin Neoplasms; Treatment Outcome	2011
Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT. Photodiagnosis and photodynamic therapy, 2010, Volume: 7, Issue:2 Topics: Aged; Aminolevulinic Acid; Dose-Response Relationship, Drug; Fluorescence; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reproducibility of Results; Skin; Skin Neoplasms	2010
Keratoacanthoma aggravated after photodynamic therapy. The Journal of dermatology, 2010, Volume: 37, Issue:8 Topics: Aminolevulinic Acid; Disease Progression; Humans; Keratoacanthoma; Male; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2010
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers in surgery and medicine, 2010, Volume: 42, Issue:7 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photobleaching; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Skin Diseases; Skin Neoplasms; Treatment Outcome	2010
Topical methyl aminolaevulinate-photodynamic therapy in erosive facial mycosis fungoides. The British journal of dermatology, 2010, Volume: 163, Issue:4 Topics: Aged, 80 and over; Aminolevulinic Acid; Facial Neoplasms; Humans; Male; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2010
Pre-surgical mapping of cutaneous non-melanoma carcinoma using topical methyl aminolevulinic acid. The British journal of oral & maxillofacial surgery, 2011, Volume: 49, Issue:7 Topics: Administration, Cutaneous; Aminolevulinic Acid; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fiducial Markers; Humans; Photosensitizing Agents; Preoperative Care; Skin Neoplasms; Ultraviolet Rays	2011
Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. Journal of photochemistry and photobiology. B, Biology, 2011, Feb-07, Volume: 102, Issue:2 Topics: Administration, Topical; Aminolevulinic Acid; Animals; Anthracenes; Antineoplastic Agents; Disease Models, Animal; Female; Keratosis, Actinic; Mice; Mice, Hairless; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Ultraviolet Rays	2011
Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:8 Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Extremities; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Sex Factors; Skin Neoplasms; Torso; Treatment Outcome	2011
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Photodiagnosis and photodynamic therapy, 2011, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Combinations; Female; Humans; Male; Metabolic Clearance Rate; Microscopy, Fluorescence; Middle Aged; Organ Specificity; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Treatment Outcome	2011
Photodynamic diagnosis of tumor margins using methyl aminolevulinate before Mohs micrographic surgery. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:5 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Middle Aged; Mohs Surgery; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Spectrometry, Fluorescence	2011
Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. Journal of cellular biochemistry, 2011, Volume: 112, Issue:9 Topics: Aminolevulinic Acid; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Nucleus Shape; Cell Shape; Cell Survival; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Ubiquitin-Protein Ligases	2011
Fluorescence diagnostics of basal cell carcinomas comparing methyl-aminolaevulinate and aminolaevulinic acid and correlation with visual clinical tumour size. Acta dermato-venereologica, 2011, Volume: 91, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Aminolevulinic Acid; Automation, Laboratory; Carcinoma, Basal Cell; Female; Fluorescence; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Predictive Value of Tests; Skin Neoplasms; Sweden; Treatment Outcome; Tumor Burden	2011
Photodynamic therapy with methyl-aminolevulinate for the treatment of double extramammary Paget's disease. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:7 Topics: Aged; Aminolevulinic Acid; Axilla; Humans; Male; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2011
Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:7 Topics: Aminolevulinic Acid; Basal Cell Nevus Syndrome; Humans; Patient Satisfaction; Photochemotherapy; Skin Neoplasms	2011
Photodynamic therapy in the treatment of extensive Bowen's disease. The Journal of dermatological treatment, 2012, Volume: 23, Issue:6 Topics: Aminolevulinic Acid; Bowen's Disease; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2012
Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2011, Volume: 20, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Chromosomes, Artificial, Bacterial; Facial Neoplasms; Humans; Photosensitizing Agents; Skin Neoplasms	2011
Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients. Acta dermato-venereologica, 2012, Volume: 92, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Retrospective Studies; Skin Neoplasms; Young Adult	2012
Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid. Acta dermato-venereologica, 2012, Volume: 92, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Photosensitizing Agents; Skin Neoplasms; Torso	2012
Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. Acta dermato-venereologica, 2012, Volume: 92, Issue:3 Topics: Adult; Aged; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Occlusive Dressings; Photochemotherapy; Photosensitizing Agents; Republic of Korea; Skin Neoplasms	2012
Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT). Photomedicine and laser surgery, 2012, Volume: 30, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Biopsy, Needle; Carcinoma, Basal Cell; Cohort Studies; Combined Modality Therapy; Esthetics; Face; Female; Follow-Up Studies; Humans; Immunohistochemistry; Laser Therapy; Male; Middle Aged; Photochemotherapy; Prospective Studies; Risk Assessment; Skin Neoplasms; Treatment Outcome; Ultrasonography	2012
Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. Experimental dermatology, 2012, Volume: 21, Issue:4 Topics: Administration, Topical; Aminolevulinic Acid; Animals; Biological Availability; Female; Humans; Mice; Mice, Hairless; Microscopy, Fluorescence; Models, Animal; Photochemotherapy; Photosensitizing Agents; Porphyrins; Precancerous Conditions; Protoporphyrins; Skin; Skin Neoplasms; Tissue Distribution; Ultraviolet Rays	2012
Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clinical and experimental dermatology, 2012, Volume: 37, Issue:4 Topics: Adult; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Immunocompromised Host; Male; Middle Aged; Organ Transplantation; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. International journal of dermatology, 2012, Volume: 51, Issue:4 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. The British journal of dermatology, 2013, Volume: 168, Issue:1 Topics: Aminolevulinic Acid; Dose-Response Relationship, Radiation; Europe; Geography, Medical; Humans; Israel; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Radiometry; Residence Characteristics; Seasons; Skin Neoplasms; Sunlight; Temperature; Ultraviolet Rays; Weather	2013
Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid? Photodermatology, photoimmunology & photomedicine, 2012, Volume: 28, Issue:5 Topics: Administration, Topical; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Male; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits. The British journal of dermatology, 2013, Volume: 168, Issue:4 Topics: Aged; Aminolevulinic Acid; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2013
Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma. The British journal of dermatology, 2013, Volume: 168, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dermoscopy; Female; Follow-Up Studies; Humans; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Sensitivity and Specificity; Skin Neoplasms; Treatment Outcome	2013
Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome. Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:11 Topics: Aminolevulinic Acid; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Female; Humans; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Urticaria	2012
Noninvasive assessment for noninvasive treatments in dermato-oncology. The British journal of dermatology, 2013, Volume: 168, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2013
Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Back; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Leg; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Radiometry; Scalp; Skin Neoplasms; Sunlight; Thorax; Treatment Outcome	2014
[An unsurpassed duo in control of skin cancer. Metvix and Aktilite]. Krankenpflege Journal, 2003, Volume: 41, Issue:1-3 Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Survival; Hematoporphyrin Photoradiation; Humans; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms	2003
[In actinic keratosis and basal cell carcinoma. The power of light heals without scars]. MMW Fortschritte der Medizin, 2003, Mar-27, Volume: 145, Issue:13 Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis; Middle Aged; Ointments; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Ultraviolet Rays	2003
Photodynamic therapy for subungual Bowen's disease. The Australasian journal of dermatology, 2004, Volume: 45, Issue:3 Topics: Adult; Aminolevulinic Acid; Bowen's Disease; Humans; Male; Nails; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2004
[Eliminating light-induced skin cancer without operation]. Krankenpflege Journal, 2004, Volume: 42, Issue:3-4 Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Basal Cell; Hematoporphyrin Photoradiation; Humans; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms; Sunlight; Treatment Outcome	2004
Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. The British journal of dermatology, 2005, Volume: 152, Issue:4 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Risk Factors; Skin Neoplasms; Time Factors; Treatment Failure; Treatment Outcome	2005
Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient. Clinical and experimental dermatology, 2006, Volume: 31, Issue:1 Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Liver Transplantation; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2006
[Reader's letter concerning K. Kreutzer, B.Bonnekoh, I. Franke, H. Gollnick. Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (Photdyn 501): practical experiences in problem patients with actinic keratoses and basa Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:5 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2005
Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. The British journal of dermatology, 2006, Volume: 154, Issue:4 Topics: Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Female; Genetic Predisposition to Disease; Heterozygote; Mice; Mice, Transgenic; Neoplasms, Radiation-Induced; Patched Receptors; Patched-1 Receptor; Photochemotherapy; Photosensitizing Agents; Receptors, Cell Surface; Skin Neoplasms; Ultraviolet Rays	2006
Chemopreventative thoughts for photodynamic therapy. Dermatologic clinics, 2007, Volume: 25, Issue:1 Topics: Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Humans; Keratosis; Mice; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2007
Photodynamic therapy for cutaneous verrucous carcinoma. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:3 Topics: Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Verrucous; Chronic Disease; Drug Administration Schedule; Humans; Leg Dermatoses; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2007
Nodular basal cell carcinoma: when in doubt, cut it out. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2007
A new method for photodynamic therapy of melanotic melanoma -- effects of depigmentation with violet light photodynamic therapy. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2007, Volume: 26, Issue:3 Topics: Aminolevulinic Acid; Animals; Female; Humans; Light; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Skin Pigmentation	2007
Allergic reactions to Metvix (ALA-ME). Contact dermatitis, 2008, Volume: 58, Issue:3 Topics: Allergens; Aminolevulinic Acid; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Patch Tests; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2008
Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation. Archives of dermatology, 2008, Volume: 144, Issue:2 Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Apoptosis; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Caspase 3; Enzyme Activation; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microscopy, Electron; Middle Aged; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms	2008